MEF2 Is restricted to the male gonad and regulates expression of the orphan nuclear receptor NR4A1

Molecular Endocrinology

Volumn 28, Issue 6, 2014, Pages 886-898

  Daems, Caroline ^a   Martin, Luc J ^a   Brousseau, Catherine ^a   Tremblay, Jacques J ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; FORSKOLIN; GONADOTROPIN; LUTEINIZING HORMONE; MESSENGER RNA; MYOCYTE ENHANCER FACTOR 2; NUCLEAR RECEPTOR NUR77; SMALL INTERFERING RNA; CAMK1 PROTEIN, MOUSE; NR4A1 PROTEIN, MOUSE; PROTEIN BINDING;

ADULT; ADULTHOOD; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GONAD DEVELOPMENT; HORMONAL REGULATION; LEYDIG CELL; MALE; MOUSE; NEWBORN; NONHUMAN; NR4A1 GENE; ORGANOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR GENE; SERTOLI CELL; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; SOMATIC CELL; STEROIDOGENESIS; TESTIS DEVELOPMENT; ANIMAL; ANTIBODY SPECIFICITY; CELL LINE; CONSENSUS SEQUENCE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; OVARY; RAT;

ANIMALS; BASE SEQUENCE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CELL LINE; CONSENSUS SEQUENCE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; LEYDIG CELLS; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; ORGAN SPECIFICITY; OVARY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS;

EID: 84901947029     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2013-1407     Document Type: Article

References (59)

1. Hazel TG, Nathans D, Lau LF. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA. 1988;85:8444-8448.
2. Kagaya S, Ohkura N, Tsukada T, et al. Prostaglandin A2 acts as a transactivator for NOR1 (NR4A3) within the nuclear receptor superfamily. Biol Pharm Bull. 2005;28:1603-1607.
3. Katagiri Y, Hirata Y, Milbrandt J, Guroff G. Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor. J Biol Chem. 1997;272:31278-31284.
4. Martin LJ, Tremblay JJ. The human 3β-hydroxysteroid dehydrogenase/ Δ5-Δ4 isomerase type 2 promoter is a novel target for the immediate early orphan nuclear receptor Nur77 in steroidogenic cells. Endocrinology. 2005;146:861-869.
5. Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic β-cell line INS-1. Diabetes. 1999;48:2007-2014.
6. Sohn YC, Kwak E, Na Y, Lee JW, Lee SK. Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77. J Biol Chem. 2001;276:43734-43739.
7. Tetradis S, Bezouglaia O, Tsingotjidou A, Vila A. Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone. Biochem Biophys Res Commun. 2001;281:913-916.
8. Williams GT, Lau LF. Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediateearly and delayed-early responses. Mol Cell Biol. 1993;13:6124-6136.
9. Wilson TE, Fahrner TJ, Milbrandt J. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol. 1993;13:5794-5804.
10. Maira M, Martens C, Philips A, Drouin J. Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol Cell Biol. 1999;19: 7549-7557.
11. Philips A, Lesage S, Gingras R, et al. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol. 1997; 17:5946-5951.
12. Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 1995;9:769-782.
13. Zetterström RH, Solomin L, Mitsiadis T, Olson L, Perlmann T. Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol Endocrinol. 1996;10:1656-1666.
14. Eells JB, Witta J, Otridge JB, Zuffova E, Nikoderm VM. Structure and function of the Nur77 receptor subfamily, a unique class of hormone nuclear receptors. Curr Genomics. 2000;1:135-152.
15. Maxwell MA, Muscat GE. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal. 2006;4:e002.
16. Li W, Amri H, Huang H, Wu C, Papadopoulos. Gene and protein profiling of the response of MA-10 Leydig tumor cells to human chorionic gonadotropin. J Androl. 2004;25:900-913.
17. Park JI, Park HJ, Choi HS, Lee K, Lee WK, Chun SY. Gonadotropin regulation of NGFI-B messenger ribonucleic acid expression during ovarian follicle development in the rat. Endocrinology. 2001;142: 3051-3059.
18. Park JI, Park HJ, Lee YI, Seo YM, Chun SY. Regulation of NGFI-B expression during the ovulatory process. Mol Cell Endocrinol. 2003;202:25-29.
19. Song KH, Park JI, Lee MO, Soh J, Lee K, Choi HS. LH induces orphan nuclear receptor Nur77 gene expression in testicular Leydig cells. Endocrinology. 2001;142:5116-5123.
20. Martin LJ, Boucher N, Brousseau C, Tremblay JJ. The orphan nuclear receptor NUR77 regulates hormone-induced StAR transcription in Leydig cells through cooperation with Ca2+/calmodulin-dependent protein kinase I. Mol Endocrinol. 2008;22:2021-2037.
21. Martin LJ, Tremblay JJ. Glucocorticoids antagonize cAMP-induced Star transcription in Leydig cells through the orphan nuclear receptor NR4A1. J Mol Endocrinol. 2008;41:165-175.
22. Martin LJ, Tremblay JJ. The nuclear receptors NUR77 and SF1 play additive roles with c-JUN through distinct elements on the mouse Star promoter. J Mol Endocrinol. 2009;42:119-129.
23. Hong CY, Park JH, Ahn RS, et al. Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor α. Mol Cell Biol. 2004;24:2593-2604.
24. Zhang P, Mellon SH. Multiple orphan nuclear receptors converge to regulate rat P450c17 gene transcription: novel mechanisms for orphan nuclear receptor action. Mol Endocrinol. 1997;11:891-904.
25. Martin LJ, Boucher N, El-Asmar B, Tremblay JJ. cAMP-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a CaMKI pathway. J Androl. 2009;30:134-145.
26. Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development. 2007;134:4131-4140.
27. McKinsey TA, Zhang CL, Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci. 2002;27:40-47.
28. Woronicz JD, Lina A, Calnan BJ, Szychowski S, Cheng L, Winoto A. Regulation of the Nur77 orphan steroid receptor in activationinduced apoptosis. Mol Cell Biol. 1995;15:6364-6376.
29. Wayman GA, Kaech S, Grant WF, et al. Regulation of axonal extension and growth cone motility by calmodulin-dependent protein kinase I. J Neurosci. 2004;24:3786-3794.
30. Guigon CJ, Coudouel N, Mazaud-Guittot S, Forest MG, Magre S. Follicular cells acquire Sertoli cell characteristics after oocyte loss. Endocrinology. 2005;146:2992-3004.
31. Robert NM, Martin LJ, Tremblay JJ. The orphan nuclear receptor NR4A1 regulates insulin-like 3 gene transcription in Leydig cells. Biol Reprod. 2006;74:322-330.
32. Ascoli M. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology. 1981;108:88-95.
33. Abdou HS, Villeneuve G, Tremblay JJ. The calcium signaling pathway regulates leydig cell steroidogenesis through a transcriptional cascade involving the nuclear receptor NR4A1 and the steroidogenic acute regulatory protein. Endocrinology. 2013;154:511-520.
34. Passier R, Zeng H, Frey N, et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest. 2000;105:1395-1406.
35. Karamboulas C, Dakubo GD, Liu J, et al. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis. J Cell Sci. 2006;119:4315-4321.
36. Karamboulas C, Swedani A, Ward C, et al. HDACactivity regulates entry of mesoderm cells into the cardiac muscle lineage. J Cell Sci. 2006;119:4305-4314.
37. Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol. 2004;18:279-290.
38. Bassett MH, White PC, Rainey WE. A role for the NGFI-B family in adrenal zonation and adrenocortical disease. Endocr Res. 2004;30: 567-574.
39. Stocco CO, Lau LF, Gibori G. A calcium/calmodulin-dependent activation of ERK1/2 mediates JunD phosphorylation and induction of nur77 and 20α-hsd genes by prostaglandin F2α in ovarian cells. J Biol Chem. 2002;277:3293-3302.
40. Youn HD, Chatila TA, Liu JO. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 2000;19:4323-4331.
41. McClelland K, Bowles J, Koopman P. Male sex determination: insights into molecular mechanisms. Asian J Androl. 2012;14:164-171.
42. Barsoum IB, Kaur J, Ge RS, Cooke PS, Yao HH. Dynamic changes in fetal Leydig cell populations influence adult Leydig cell populations in mice. FASEB J. 2013;27:2657-2666.
43. Brennan J, Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet. 2004;5:509-521.
44. Naya FJ, Black BL, Wu H, et al. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med. 2002;8:1303-1309.
45. Kim Y, Phan D, van Rooij E, et al. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest. 2008;118:124-132.
46. Youn HD, Liu JO. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity. 2000;13:85-94.
47. Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH. Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem. 1998;273:18325-18331.
48. Dressel U, Bailey PJ, Wang SC, Downes M, Evans RM, Muscat GE. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem. 2001;276:17007-17013.
49. Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 1999;18:5099-5107.
50. Sparrow DB, Miska EA, Langley E, et al. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 1999;18:5085-5098.
51. McKinsey TA, Zhang CL, Olson EN. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci USA. 2000;97:14400-14405.
52. McKinsey TA, Zhang CL, Olson EN. Identification of a signalresponsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol. 2001;21:6312-6321.
53. Costa RR, Varanda WA, Franci CR. A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells. Am J Physiol Cell Physiol. 2010;299:C316-C323.
54. Park SY, Shin HM, Han TH. Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter. Mol Immunol. 2002;39: 25-30.
55. Maeda T, Gupta MP, Stewart AF. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem Biophys Res Commun. 2002;294:791-797.
56. Blaeser F, Ho N, Prywes R, Chatila TA. Ca(2+)-dependent gene expression mediated by MEF2 transcription factors. J Biol Chem. 2000;275:197-209.
57. Chai WR, Wang Q, Gao HB. NFAT2 is implicated in corticosterone-induced rat Leydig cell apoptosis. Asian J Androl. 2007;9: 623-633.
58. Ketola I, Rahman N, Toppari J, et al. Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology. 1999;140:1470-1480.
59. Morin S, Charron F, Robitaille L, Nemer M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 2000;19:2046-2055.